|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
5R01CA172105-03
|
$401,456
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Platelets promote growth of ovarian cancer
|
5R01CA177909-05
|
$332,000
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Clinical and Laboratory Research Training for Surgical Oncologists
|
5T32CA126607-09
|
$438,202
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-05
|
$357,673
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
|
5U01CA194389-03
|
$643,804
|
ALIZADEH, ARASH
|
STANFORD UNIVERSITY
|
|
SURFACE ANTIGENS OF MURINE T LYMPHOMAS
|
5R01CA040041-23
|
$311,649
|
ALLISON, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-02
|
$520,564
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Regulation of mitosis by proteolysis in yeast
|
5R01CA206157-22
|
$289,175
|
AMON, ANGELIKA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Integrative analysis of lung cancer etiology and risk
|
1U19CA203654-01A1
|
$2,833,706
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
1UG3CA211415-01
|
$375,888
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of Tim-3 in determining T cell immunity
|
5R01CA187975-03
|
$377,666
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
Anderson, William
|
DCEG (NCI)
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
Anderson, William
|
DCEG (NCI)
|
|
Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
|
1R01CA211080-01
|
$616,246
|
ANDRONESI, OVIDIU
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Control of Papillomavirus Expression and Transformation
|
5R01CA058376-22
|
$370,500
|
ANDROPHY, ELLIOT
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
5R01CA201225-02
|
$500,397
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Cancer Cytogenetics
|
Z01 BC 010694
|
$450,091
|
Arthur, Diane
|
CCR (NCI)
|
|
T Cell Alternative p38 Activation Pathway
|
Z01 BC 010774
|
$431,955
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
Z01 BC 010779
|
$431,955
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Personalized vaccine for patients with AML
|
1R01CA212649-01
|
$739,429
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Radiolabeled FASN Inhibitors for PET Imaging
|
1R21CA213157-01
|
$229,013
|
BABICH, JOHN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
University of Washington Center for Aids Research
|
P30AI027757-30
|
$455,194
|
Baeten, Jared
|
UNIVERSITY OF WASHINGTON
|
|
Elucidating the role of CD26 in T cell-mediated tumor immunity
|
5F31CA192787-03
|
$44,044
|
BAILEY, STEFANIE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
|
5R01CA168621-04
|
$379,725
|
BALACHANDRAN, SIDDHARTH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
5R35CA197684-02
|
$848,325
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
5P01CA163227-05
|
$2,045,478
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Deregulation of Cellular IkB Kinases by HTLV1 Tax
|
5R01CA082556-09
|
$421,051
|
BALLARD, DEAN
|
VANDERBILT UNIVERSITY
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Characterization of replication-mediated DNA damage in B lymphocytes
|
5K22CA188106-03
|
$162,000
|
BARLOW, JACQUELINE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The roles of TRIM24 in breast cancer
|
1R01CA214871-01
|
$402,021
|
BARTON, MICHELLE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Dopamine as a therapeutic agent in stomach cancer
|
5R01CA169158-05
|
$319,550
|
BASU, SUJIT
|
OHIO STATE UNIVERSITY
|
|
Targeting HPV Consequences in a Cervical Cancer Clinical Trial
|
5R01CA200126-02
|
$425,061
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Role of KDM5A in pRB-mediated differentiation
|
1R01CA211095-01
|
$365,771
|
BENEVOLENSKAYA, ELIZAVETA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Summer Program to Advance Research Careers (SPARC)
|
1R25CA214256-01
|
$270,412
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Pulmonary Rehabiltation before Lung Cancer Resection
|
5R01CA163293-06
|
$268,352
|
BENZO, ROBERTO
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
5P30CA022453-35
|
$2,562,428
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Biochemical Analyses of Type II DNA Topoisomerases
|
5R01CA077373-20
|
$445,382
|
BERGER, JAMES
|
JOHNS HOPKINS UNIVERSITY
|
|
Epigenetic regulation by tumor suppressor p53
|
5R01CA078831-18
|
$352,848
|
BERGER, SHELLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Lymphoma in Autoimmune Disease: Consequence of Immune Suppression or Stimulation?
|
5R03CA128052-02
|
$54,000
|
Bernatsky, Sasha
|
MCGILL UNIVERSITY HEALTH CTR RES INST
|
|
Pediatric Oncology Research Training Program
|
2T32CA009351-39
|
$272,307
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
|
1P01CA206980-01A1
|
$2,292,665
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Racism, Residential Racial Segregation, and Breast Cancer Survival Disparities among Black, Hispanic and non-Hispanic White Women
|
1R01CA214805-01
|
$462,342
|
BEYER, KIRSTEN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment
|
5R21CA193064-04
|
$240,357
|
BHATNAGAR, PARIJAT
|
SRI INTERNATIONAL
|
|
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
|
5R01CA169200-05
|
$372,320
|
BIRRER, MICHAEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
|
1R01CA211052-01
|
$362,569
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Imaging and Targeting Metastatic-Prone Breast Cancer
|
5R01CA172846-05
|
$560,220
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role of CAF-1 complex in tumor progression
|
1R03CA212562-01
|
$84,750
|
BLENIS, JOHN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|